REZOLUTE, INC. Form CORRESP: Company correspondence with SEC staff
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-08-01: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2024-08-13: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2023-11-27: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2022-11-07: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-08-01 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2024-08-13 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2023-11-27 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-11-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-06-29 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-12-29 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2020-11-23 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-12-04 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-09-16 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-09-12 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-09-09 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2019-03-28 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2018-02-09 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-11-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-11-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-10-31 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-10-13 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-01-17 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2015-07-23 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2015-07-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2014-04-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2012-12-13 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2011-08-11 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2011-08-11 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2011-07-20 | CORRESP | Company correspondence with SEC staff | filename1.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |